It has been found that Zap-70 expression enhances BCR-mediated Erk1/2 and Akt activation, which in turn enhance proliferation and survival of CLL cells [75,76,77]. This evidence concerns the gene MAPK3 and B-cell chronic lymphocytic leukemia.